Twist Bioscience Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
-46.61
Forward P/E Ratio
-29.55
PEG Ratio
-6.15
-33.79
Price-to-Sales (TTM)
9.21
8.27
7.32
Market Cap
3.77B
3.71B
Is it profitable?
Net Profit Margin (TTM)
-19.85%
Gross Profit Margin
51.59%
Diluted EPS (TTM)
-1.32
-18.16%
409.48M
Is it growing?
19.30%
19.31%
Is it risky?
2.23
24.36
2.70
110.84M
Who owns it?
123.89%
1.32%
28.67%
62.15M
55.41M
Does it pay?
0.00%
0.00%
--
--
How much cash?
171.67M
-55.59M
-58.48M
2.76
- Price
- 60.57
- Percent Change
- +1.74 (2.95%)
- Previous Close
- 58.84
- Open
- 58.50
- Low
- 56.67
- High
- 61.93
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$60.57
From 52W Low
+159.96%
From 52W High
-8.31%
Today
+2.95%
1Y Change
+105.95%
6M
$31.11
3M
$49.58
1M
$61.00
Today
$60.57
From 52W Low
+159.96%
From 52W High
-8.31%
Today
+2.95%
1Y Change
+105.95%
6M
$31.11
3M
$49.58
1M
$61.00
Today
$60.57
Expensive
within its 1-year price range
$60.57
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.7%
3M
+22.2%
6M
+94.7%
1Y
+106.0%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- 2013
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2024
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com
Indicators
Operating Cash Flow
-55.59M
Net Income
-81.28M
Mixed Signal
0.68
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
-55.59M
Net Income
-81.28M
Mixed Signal
0.68
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-46.61
Forward P/E Ratio
-29.55
PEG Ratio
-6.15
-33.79
Price-to-Sales (TTM)
9.21
8.27
7.32
Market Cap
3.77B
3.71B
Is it profitable?
Net Profit Margin (TTM)
-19.85%
Gross Profit Margin
51.59%
Diluted EPS (TTM)
-1.32
-18.16%
409.48M
Is it growing?
19.30%
19.31%
Is it risky?
2.23
24.36
2.70
110.84M
Who owns it?
123.89%
1.32%
28.67%
62.15M
55.41M
Does it pay?
0.00%
0.00%
--
--
How much cash?
171.67M
-55.59M
-58.48M
2.76
- Price
- 60.57
- Percent Change
- +1.74 (2.95%)
- Previous Close
- 58.84
- Open
- 58.50
- Low
- 56.67
- High
- 61.93
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$60.57
From 52W Low
+159.96%
From 52W High
-8.31%
Today
+2.95%
1Y Change
+105.95%
6M
$31.11
3M
$49.58
1M
$61.00
Today
$60.57
From 52W Low
+159.96%
From 52W High
-8.31%
Today
+2.95%
1Y Change
+105.95%
6M
$31.11
3M
$49.58
1M
$61.00
Today
$60.57
Expensive
within its 1-year price range
$60.57
Multi-Timeframe Analysis (MTA)
Pullback
A brief dip inside a longer uptrend. Pullbacks are normal and healthy. They often represent buying opportunities when the broader multi-period trend remains intact. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-0.7%
3M
+22.2%
6M
+94.7%
1Y
+106.0%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- 2013
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2024
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |